Alexion Pharmaceuticals, Inc.
(NASDAQ GS: ALXN)
Rigrodsky Law, P.A. is investigating Alexion Pharmaceuticals, Inc. (“Alexion”) regarding possible breaches of fiduciary duties and other violations of law related to Alexion’s agreement to be acquired by AstraZeneca PLC ("AstraZeneca"). Under the terms of the agreement, Alexion's shareholders will receive 2.1243 American Depository Shares of AstraZeneca and $60.00 in cash per share.